UniProt ID | DREB_HUMAN | |
---|---|---|
UniProt AC | Q16643 | |
Protein Name | Drebrin | |
Gene Name | DBN1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 649 | |
Subcellular Localization | Cytoplasm . Cytoplasm, cell cortex . Cell junction . Cell projection . Cell projection, growth cone . In the absence of antigen, evenly distributed throughout subcortical regions of the T-cell membrane and cytoplasm. In the presence of antigen, distr | |
Protein Description | Drebrins might play some role in cell migration, extension of neuronal processes and plasticity of dendrites. Required for actin polymerization at immunological synapses (IS) and for CXCR4 recruitment to IS.. | |
Protein Sequence | MAGVSFSGHRLELLAAYEEVIREESAADWALYTYEDGSDDLKLAASGEGGLQELSGHFENQKVMYGFCSVKDSQAALPKYVLINWVGEDVPDARKCACASHVAKVAEFFQGVDVIVNASSVEDIDAGAIGQRLSNGLARLSSPVLHRLRLREDENAEPVGTTYQKTDAAVEMKRINREQFWEQAKKEEELRKEEERKKALDERLRFEQERMEQERQEQEERERRYREREQQIEEHRRKQQTLEAEEAKRRLKEQSIFGDHRDEEEETHMKKSESEVEEAAAIIAQRPDNPREFFKQQERVASASAGSCDVPSPFNHRPGSHLDSHRRMAPTPIPTRSPSDSSTASTPVAEQIERALDEVTSSQPPPLPPPPPPAQETQEPSPILDSEETRAAAPQAWAGPMEEPPQAQAPPRGPGSPAEDLMFMESAEQAVLAAPVEPATADATEIHDAADTIETDTATADTTVANNVPPAATSLIDLWPGNGEGASTLQGEPRAPTPPSGTEVTLAEVPLLDEVAPEPLLPAGEGCATLLNFDELPEPPATFCDPEEVEGESLAAPQTPTLPSALEELEQEQEPEPHLLTNGETTQKEGTQASEGYFSQSQEEEFAQSEELCAKAPPPVFYNKPPEIDITCWDADPVPEEEEGFEGGD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAGVSFSGH ------CCCCCCCHH | 27.39 | 19413330 | |
5 | Phosphorylation | ---MAGVSFSGHRLE ---CCCCCCCHHHHH | 16.87 | 25159151 | |
6 | Phosphorylation | --MAGVSFSGHRLEL --CCCCCCCHHHHHH | 10.61 | 32142685 | |
7 | Phosphorylation | -MAGVSFSGHRLELL -CCCCCCCHHHHHHH | 26.61 | 28355574 | |
8 | Ubiquitination | MAGVSFSGHRLELLA CCCCCCCHHHHHHHH | 14.13 | 23000965 | |
17 | Phosphorylation | RLELLAAYEEVIREE HHHHHHHHHHHHHHH | 13.66 | 28674151 | |
32 | Phosphorylation | SAADWALYTYEDGSD CCCCEEEEEECCCCC | 10.26 | 28796482 | |
33 | Phosphorylation | AADWALYTYEDGSDD CCCEEEEEECCCCCC | 22.68 | 28796482 | |
34 | Phosphorylation | ADWALYTYEDGSDDL CCEEEEEECCCCCCC | 9.85 | 28796482 | |
34 (in isoform 2) | Phosphorylation | - | 9.85 | 27642862 | |
36 (in isoform 2) | Phosphorylation | - | 52.03 | 27642862 | |
51 | Ubiquitination | AASGEGGLQELSGHF ECCCCCHHHHHHCCC | 5.41 | 23000965 | |
60 | Ubiquitination | ELSGHFENQKVMYGF HHHCCCCCCEEEEEE | 46.13 | 23000965 | |
62 | Ubiquitination | SGHFENQKVMYGFCS HCCCCCCEEEEEEEC | 40.32 | - | |
62 | Acetylation | SGHFENQKVMYGFCS HCCCCCCEEEEEEEC | 40.32 | 26051181 | |
62 | Ubiquitination | SGHFENQKVMYGFCS HCCCCCCEEEEEEEC | 40.32 | 23000965 | |
63 | Phosphorylation | GHFENQKVMYGFCSV CCCCCCEEEEEEECH | 2.29 | 32142685 | |
64 | Sulfoxidation | HFENQKVMYGFCSVK CCCCCEEEEEEECHH | 3.31 | 30846556 | |
64 | Ubiquitination | HFENQKVMYGFCSVK CCCCCEEEEEEECHH | 3.31 | 23000965 | |
65 | Phosphorylation | FENQKVMYGFCSVKD CCCCEEEEEEECHHC | 15.27 | 25159151 | |
67 | Phosphorylation | NQKVMYGFCSVKDSQ CCEEEEEEECHHCHH | 1.22 | - | |
69 | Phosphorylation | KVMYGFCSVKDSQAA EEEEEEECHHCHHHC | 29.91 | 32142685 | |
70 | Ubiquitination | VMYGFCSVKDSQAAL EEEEEECHHCHHHCC | 9.33 | 32015554 | |
71 | Ubiquitination | MYGFCSVKDSQAALP EEEEECHHCHHHCCC | 35.05 | 21906983 | |
71 | Acetylation | MYGFCSVKDSQAALP EEEEECHHCHHHCCC | 35.05 | 26051181 | |
71 | Phosphorylation | MYGFCSVKDSQAALP EEEEECHHCHHHCCC | 35.05 | 32142685 | |
71 | Ubiquitination | MYGFCSVKDSQAALP EEEEECHHCHHHCCC | 35.05 | 23000965 | |
71 (in isoform 1) | Ubiquitination | - | 35.05 | 21906983 | |
73 | Phosphorylation | GFCSVKDSQAALPKY EEECHHCHHHCCCCE | 18.92 | 27251275 | |
73 | Ubiquitination | GFCSVKDSQAALPKY EEECHHCHHHCCCCE | 18.92 | 23000965 | |
73 (in isoform 2) | Ubiquitination | - | 18.92 | 21906983 | |
75 | Phosphorylation | CSVKDSQAALPKYVL ECHHCHHHCCCCEEE | 18.21 | 27251275 | |
78 | Phosphorylation | KDSQAALPKYVLINW HCHHHCCCCEEEEEC | 22.62 | 32645325 | |
79 | Acetylation | DSQAALPKYVLINWV CHHHCCCCEEEEECC | 49.17 | 26051181 | |
79 | Ubiquitination | DSQAALPKYVLINWV CHHHCCCCEEEEECC | 49.17 | 29967540 | |
80 | Phosphorylation | SQAALPKYVLINWVG HHHCCCCEEEEECCC | 9.88 | 28796482 | |
81 | Ubiquitination | QAALPKYVLINWVGE HHCCCCEEEEECCCC | 5.59 | 29967540 | |
96 | S-nitrosylation | DVPDARKCACASHVA CCCCHHHHHHHHHHH | 2.91 | 2212679 | |
110 | Ubiquitination | AKVAEFFQGVDVIVN HHHHHHHCCCCEEEC | 57.21 | 24816145 | |
113 | Phosphorylation | AEFFQGVDVIVNASS HHHHCCCCEEECCCC | 31.11 | 32142685 | |
134 | Phosphorylation | GAIGQRLSNGLARLS CHHHHHHHHHHHHHC | 30.92 | 30266825 | |
136 | Phosphorylation | IGQRLSNGLARLSSP HHHHHHHHHHHHCCH | 19.82 | 20068231 | |
141 | Phosphorylation | SNGLARLSSPVLHRL HHHHHHHCCHHHHHH | 27.35 | 25159151 | |
142 | Phosphorylation | NGLARLSSPVLHRLR HHHHHHCCHHHHHHH | 24.50 | 29255136 | |
142 (in isoform 3) | Phosphorylation | - | 24.50 | - | |
143 | Phosphorylation | GLARLSSPVLHRLRL HHHHHCCHHHHHHHC | 29.34 | 20068231 | |
144 | Phosphorylation | LARLSSPVLHRLRLR HHHHCCHHHHHHHCC | 8.31 | 18707149 | |
161 | Phosphorylation | ENAEPVGTTYQKTDA CCCCCCCCCEECCHH | 23.67 | 21945579 | |
162 | Phosphorylation | NAEPVGTTYQKTDAA CCCCCCCCEECCHHH | 20.30 | 21945579 | |
162 | Ubiquitination | NAEPVGTTYQKTDAA CCCCCCCCEECCHHH | 20.30 | 24816145 | |
163 | Phosphorylation | AEPVGTTYQKTDAAV CCCCCCCEECCHHHH | 14.09 | 21945579 | |
165 | Acetylation | PVGTTYQKTDAAVEM CCCCCEECCHHHHHH | 37.65 | 26051181 | |
165 | Phosphorylation | PVGTTYQKTDAAVEM CCCCCEECCHHHHHH | 37.65 | - | |
172 | Ubiquitination | KTDAAVEMKRINREQ CCHHHHHHHHHCHHH | 2.58 | 32142685 | |
173 | Ubiquitination | TDAAVEMKRINREQF CHHHHHHHHHCHHHH | 36.30 | - | |
173 | 2-Hydroxyisobutyrylation | TDAAVEMKRINREQF CHHHHHHHHHCHHHH | 36.30 | - | |
173 | Acetylation | TDAAVEMKRINREQF CHHHHHHHHHCHHHH | 36.30 | 25953088 | |
173 | Ubiquitination | TDAAVEMKRINREQF CHHHHHHHHHCHHHH | 36.30 | 32015554 | |
175 | Ubiquitination | AAVEMKRINREQFWE HHHHHHHHCHHHHHH | 4.80 | 27667366 | |
227 | Ubiquitination | ERERRYREREQQIEE HHHHHHHHHHHHHHH | 52.19 | 27667366 | |
232 | Ubiquitination | YREREQQIEEHRRKQ HHHHHHHHHHHHHHH | 7.20 | 23000965 | |
238 | Ubiquitination | QIEEHRRKQQTLEAE HHHHHHHHHHHHHHH | 46.87 | - | |
238 | Ubiquitination | QIEEHRRKQQTLEAE HHHHHHHHHHHHHHH | 46.87 | 27667366 | |
240 | Ubiquitination | EEHRRKQQTLEAEEA HHHHHHHHHHHHHHH | 51.60 | 27667366 | |
241 | Phosphorylation | EHRRKQQTLEAEEAK HHHHHHHHHHHHHHH | 24.87 | 20068231 | |
243 | Phosphorylation | RRKQQTLEAEEAKRR HHHHHHHHHHHHHHH | 58.38 | 20068231 | |
247 | Ubiquitination | QTLEAEEAKRRLKEQ HHHHHHHHHHHHHHC | 11.36 | 32142685 | |
248 | Ubiquitination | TLEAEEAKRRLKEQS HHHHHHHHHHHHHCH | 41.13 | 32142685 | |
250 | Ubiquitination | EAEEAKRRLKEQSIF HHHHHHHHHHHCHHH | 49.78 | 32142685 | |
251 | Ubiquitination | AEEAKRRLKEQSIFG HHHHHHHHHHCHHHC | 9.22 | 32015554 | |
252 | Acetylation | EEAKRRLKEQSIFGD HHHHHHHHHCHHHCC | 52.47 | 26051181 | |
252 | Ubiquitination | EEAKRRLKEQSIFGD HHHHHHHHHCHHHCC | 52.47 | 32015554 | |
254 | Ubiquitination | AKRRLKEQSIFGDHR HHHHHHHCHHHCCCC | 39.99 | 32015554 | |
255 | Phosphorylation | KRRLKEQSIFGDHRD HHHHHHCHHHCCCCC | 22.45 | 28348404 | |
257 | Phosphorylation | RLKEQSIFGDHRDEE HHHHCHHHCCCCCHH | 13.09 | 27251275 | |
267 | Phosphorylation | HRDEEEETHMKKSES CCCHHHHHHHHHCHH | 30.46 | 27135362 | |
271 | Ubiquitination | EEETHMKKSESEVEE HHHHHHHHCHHHHHH | 52.46 | 29967540 | |
272 | Phosphorylation | EETHMKKSESEVEEA HHHHHHHCHHHHHHH | 40.62 | 30266825 | |
273 | Phosphorylation | ETHMKKSESEVEEAA HHHHHHCHHHHHHHH | 60.85 | 32142685 | |
273 | Ubiquitination | ETHMKKSESEVEEAA HHHHHHCHHHHHHHH | 60.85 | 29967540 | |
274 | Phosphorylation | THMKKSESEVEEAAA HHHHHCHHHHHHHHH | 54.77 | 30266825 | |
276 | Phosphorylation | MKKSESEVEEAAAII HHHCHHHHHHHHHHH | 12.87 | 32142685 | |
284 | Ubiquitination | EEAAAIIAQRPDNPR HHHHHHHHCCCCCHH | 8.00 | 23000965 | |
295 | Acetylation | DNPREFFKQQERVAS CCHHHHHHHHHHHHH | 57.29 | - | |
295 | Ubiquitination | DNPREFFKQQERVAS CCHHHHHHHHHHHHH | 57.29 | - | |
295 | Acetylation | DNPREFFKQQERVAS CCHHHHHHHHHHHHH | 57.29 | 25953088 | |
295 | Malonylation | DNPREFFKQQERVAS CCHHHHHHHHHHHHH | 57.29 | 26320211 | |
295 | Succinylation | DNPREFFKQQERVAS CCHHHHHHHHHHHHH | 57.29 | 23954790 | |
295 | Ubiquitination | DNPREFFKQQERVAS CCHHHHHHHHHHHHH | 57.29 | 23000965 | |
297 | Acetylation | PREFFKQQERVASAS HHHHHHHHHHHHHCC | 40.84 | - | |
297 | Ubiquitination | PREFFKQQERVASAS HHHHHHHHHHHHHCC | 40.84 | 23000965 | |
302 | Phosphorylation | KQQERVASASAGSCD HHHHHHHHCCCCCCC | 21.65 | 24732914 | |
304 | Phosphorylation | QERVASASAGSCDVP HHHHHHCCCCCCCCC | 30.57 | 24732914 | |
307 | Phosphorylation | VASASAGSCDVPSPF HHHCCCCCCCCCCCC | 13.58 | 24732914 | |
309 | Phosphorylation | SASAGSCDVPSPFNH HCCCCCCCCCCCCCC | 57.99 | 27251275 | |
312 | Phosphorylation | AGSCDVPSPFNHRPG CCCCCCCCCCCCCCC | 41.81 | 23401153 | |
314 | Phosphorylation | SCDVPSPFNHRPGSH CCCCCCCCCCCCCCC | 16.45 | 20068231 | |
320 | Phosphorylation | PFNHRPGSHLDSHRR CCCCCCCCCCCCCCC | 24.45 | 28348404 | |
322 | Phosphorylation | NHRPGSHLDSHRRMA CCCCCCCCCCCCCCC | 8.49 | 27251275 | |
322 (in isoform 3) | Phosphorylation | - | 8.49 | 28985074 | |
324 | Phosphorylation | RPGSHLDSHRRMAPT CCCCCCCCCCCCCCC | 25.83 | 24732914 | |
326 | Phosphorylation | GSHLDSHRRMAPTPI CCCCCCCCCCCCCCC | 33.74 | - | |
328 | Sulfoxidation | HLDSHRRMAPTPIPT CCCCCCCCCCCCCCC | 5.44 | 21406390 | |
329 (in isoform 3) | Phosphorylation | - | 11.73 | 26552605 | |
331 | Phosphorylation | SHRRMAPTPIPTRSP CCCCCCCCCCCCCCC | 25.06 | 29255136 | |
331 (in isoform 3) | Phosphorylation | - | 25.06 | 26552605 | |
333 | Phosphorylation | RRMAPTPIPTRSPSD CCCCCCCCCCCCCCC | 6.31 | 32645325 | |
334 (in isoform 3) | Phosphorylation | - | 23.98 | 26552605 | |
335 | Phosphorylation | MAPTPIPTRSPSDSS CCCCCCCCCCCCCCC | 44.49 | 29255136 | |
335 (in isoform 3) | Phosphorylation | - | 44.49 | 24719451 | |
336 (in isoform 3) | Phosphorylation | - | 41.01 | 26552605 | |
337 | Phosphorylation | PTPIPTRSPSDSSTA CCCCCCCCCCCCCCC | 31.10 | 29255136 | |
337 (in isoform 3) | Phosphorylation | - | 31.10 | 26552605 | |
338 (in isoform 3) | Phosphorylation | - | 38.57 | 26552605 | |
339 | Phosphorylation | PIPTRSPSDSSTAST CCCCCCCCCCCCCCC | 51.90 | 29255136 | |
339 (in isoform 3) | Phosphorylation | - | 51.90 | 26552605 | |
340 (in isoform 3) | Phosphorylation | - | 50.41 | 26552605 | |
341 | Phosphorylation | PTRSPSDSSTASTPV CCCCCCCCCCCCCHH | 33.65 | 29255136 | |
341 (in isoform 3) | Phosphorylation | - | 33.65 | 26552605 | |
342 | Phosphorylation | TRSPSDSSTASTPVA CCCCCCCCCCCCHHH | 32.74 | 29255136 | |
342 (in isoform 3) | Phosphorylation | - | 32.74 | 28985074 | |
343 | Phosphorylation | RSPSDSSTASTPVAE CCCCCCCCCCCHHHH | 28.69 | 29255136 | |
344 | Phosphorylation | SPSDSSTASTPVAEQ CCCCCCCCCCHHHHH | 17.23 | 15345747 | |
345 | Phosphorylation | PSDSSTASTPVAEQI CCCCCCCCCHHHHHH | 33.08 | 22167270 | |
346 | Phosphorylation | SDSSTASTPVAEQIE CCCCCCCCHHHHHHH | 21.22 | 23927012 | |
347 | Phosphorylation | DSSTASTPVAEQIER CCCCCCCHHHHHHHH | 22.33 | 19664995 | |
348 | Phosphorylation | SSTASTPVAEQIERA CCCCCCHHHHHHHHH | 10.43 | 19664995 | |
360 | Phosphorylation | ERALDEVTSSQPPPL HHHHHHHHCCCCCCC | 22.18 | 24732914 | |
361 | Phosphorylation | RALDEVTSSQPPPLP HHHHHHHCCCCCCCC | 31.95 | 24732914 | |
362 | Phosphorylation | ALDEVTSSQPPPLPP HHHHHHCCCCCCCCC | 37.02 | 24732914 | |
376 | Phosphorylation | PPPPPAQETQEPSPI CCCCCCCCCCCCCCC | 55.34 | 32142685 | |
377 | Phosphorylation | PPPPAQETQEPSPIL CCCCCCCCCCCCCCC | 26.59 | 30266825 | |
377 (in isoform 3) | Phosphorylation | - | 26.59 | 27762562 | |
379 | Phosphorylation | PPAQETQEPSPILDS CCCCCCCCCCCCCCC | 55.98 | 18669648 | |
381 | Phosphorylation | AQETQEPSPILDSEE CCCCCCCCCCCCCHH | 24.66 | 30266825 | |
382 | Phosphorylation | QETQEPSPILDSEET CCCCCCCCCCCCHHH | 41.71 | 32142685 | |
383 | Phosphorylation | ETQEPSPILDSEETR CCCCCCCCCCCHHHH | 8.61 | 32142685 | |
384 | Phosphorylation | TQEPSPILDSEETRA CCCCCCCCCCHHHHH | 7.23 | 32142685 | |
385 | Phosphorylation | QEPSPILDSEETRAA CCCCCCCCCHHHHHH | 55.51 | 32142685 | |
386 | Phosphorylation | EPSPILDSEETRAAA CCCCCCCCHHHHHHC | 33.61 | 30266825 | |
389 | Phosphorylation | PILDSEETRAAAPQA CCCCCHHHHHHCCCC | 22.89 | 24732914 | |
391 | Phosphorylation | LDSEETRAAAPQAWA CCCHHHHHHCCCCCC | 18.52 | 32645325 | |
392 | Phosphorylation | DSEETRAAAPQAWAG CCHHHHHHCCCCCCC | 19.18 | 32645325 | |
401 | Sulfoxidation | PQAWAGPMEEPPQAQ CCCCCCCCCCCCCCC | 9.97 | 30846556 | |
416 | Phosphorylation | APPRGPGSPAEDLMF CCCCCCCCCHHHHHC | 24.87 | 26074081 | |
418 | Phosphorylation | PRGPGSPAEDLMFME CCCCCCCHHHHHCHH | 25.32 | - | |
426 | Phosphorylation | EDLMFMESAEQAVLA HHHHCHHHHHHHHHH | 25.89 | 32142685 | |
427 | Phosphorylation | DLMFMESAEQAVLAA HHHCHHHHHHHHHHC | 10.30 | 32142685 | |
487 | Phosphorylation | PGNGEGASTLQGEPR CCCCCCCCCCCCCCC | 40.27 | 26074081 | |
488 | Phosphorylation | GNGEGASTLQGEPRA CCCCCCCCCCCCCCC | 23.67 | 26074081 | |
497 | Phosphorylation | QGEPRAPTPPSGTEV CCCCCCCCCCCCCEE | 47.01 | 26074081 | |
499 | Phosphorylation | EPRAPTPPSGTEVTL CCCCCCCCCCCEEEE | 48.12 | - | |
500 | Phosphorylation | PRAPTPPSGTEVTLA CCCCCCCCCCEEEEE | 60.60 | 26074081 | |
502 | Phosphorylation | APTPPSGTEVTLAEV CCCCCCCCEEEEEEC | 31.45 | 26074081 | |
505 | Phosphorylation | PPSGTEVTLAEVPLL CCCCCEEEEEECCCC | 17.64 | 26074081 | |
559 | Phosphorylation | ESLAAPQTPTLPSAL CCCCCCCCCCCCHHH | 19.72 | 26074081 | |
561 | Phosphorylation | LAAPQTPTLPSALEE CCCCCCCCCCHHHHH | 55.47 | 26074081 | |
564 | Phosphorylation | PQTPTLPSALEELEQ CCCCCCCHHHHHHHH | 48.90 | 26074081 | |
566 | Phosphorylation | TPTLPSALEELEQEQ CCCCCHHHHHHHHHC | 6.53 | 17081983 | |
591 | Phosphorylation | ETTQKEGTQASEGYF CCCCCCCCCCCCCCC | 23.27 | 28122231 | |
594 | Phosphorylation | QKEGTQASEGYFSQS CCCCCCCCCCCCCCC | 23.03 | 30266825 | |
597 | Phosphorylation | GTQASEGYFSQSQEE CCCCCCCCCCCCHHH | 8.94 | 30266825 | |
599 | Phosphorylation | QASEGYFSQSQEEEF CCCCCCCCCCHHHHH | 22.04 | 30266825 | |
601 | Phosphorylation | SEGYFSQSQEEEFAQ CCCCCCCCHHHHHHH | 38.06 | 30266825 | |
603 | Phosphorylation | GYFSQSQEEEFAQSE CCCCCCHHHHHHHHH | 65.82 | 19664995 | |
609 | Phosphorylation | QEEEFAQSEELCAKA HHHHHHHHHHHHHCC | 29.61 | 30266825 | |
611 | Phosphorylation | EEFAQSEELCAKAPP HHHHHHHHHHHCCCC | 55.16 | - | |
622 | Phosphorylation | KAPPPVFYNKPPEID CCCCCCCCCCCCCCC | 23.63 | 28796482 | |
624 | Phosphorylation | PPPVFYNKPPEIDIT CCCCCCCCCCCCCEE | 51.04 | 15592455 | |
631 | Phosphorylation | KPPEIDITCWDADPV CCCCCCEEEECCCCC | 12.09 | 28796482 | |
632 | Glutathionylation | PPEIDITCWDADPVP CCCCCEEEECCCCCC | 2.94 | 22555962 | |
646 | Phosphorylation | PEEEEGFEGGD---- CHHHCCCCCCC---- | 73.46 | 32142685 | |
647 | Phosphorylation | EEEEGFEGGD----- HHHCCCCCCC----- | 43.22 | 32142685 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DREB_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DREB_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-142; THR-331; THR-335; SER-337; SER-339;THR-343; SER-345; THR-346 AND SER-601, AND MASS SPECTROMETRY. | |
"Exploring proteomes and analyzing protein processing by massspectrometric identification of sorted N-terminal peptides."; Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,Thomas G.R., Vandekerckhove J.; Nat. Biotechnol. 21:566-569(2003). Cited for: PROTEIN SEQUENCE OF 2-10, AND ACETYLATION AT ALA-2. | |
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-142; THR-331; THR-335; SER-337; SER-339;THR-343; SER-345; THR-346 AND SER-601, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-142; THR-331; THR-335;SER-337; SER-339 AND THR-346, AND MASS SPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-142 AND THR-335, ANDMASS SPECTROMETRY. | |
"Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-142 AND SER-339, ANDMASS SPECTROMETRY. | |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-142, AND MASSSPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-142 AND THR-346, ANDMASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-339, AND MASSSPECTROMETRY. | |
"Quantitative phosphoproteome analysis using a dendrimer conjugationchemistry and tandem mass spectrometry."; Tao W.A., Wollscheid B., O'Brien R., Eng J.K., Li X.-J.,Bodenmiller B., Watts J.D., Hood L., Aebersold R.; Nat. Methods 2:591-598(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-339, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-141 AND SER-142, ANDMASS SPECTROMETRY. | |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-331 AND THR-346, ANDMASS SPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-622, AND MASSSPECTROMETRY. |